SCHEMBL30786373

SCHEMBL30786373

COC(=O)c1cc2c(Cl)ccnc2cc1OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.46
NOTUM Q6P988 1/20 0.46
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
MCL1 Q07820 1/20 0.45
POLB P06746 1/20 0.44
ERBB2 P04626 1/20 0.44
CNR1 P21554 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
LMNA P02545 1/20 0.43
PLA2G2A P14555 1/20 0.43
FFAR4 Q5NUL3 1/20 0.42
LRRK2 Q5S007 1/20 0.41
PPIA P62937 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1893519 1.00 EGFR (0.46) EGFRNOTUMKDM4EALDH1A1HPGD
SCHEMBL1896473 0.88 EGFR (0.47) EGFRKDM4EALDH1A1NPC1RAB9A
SCHEMBL1893310 0.88 KMT2A (0.47) EGFRKDM4EALDH1A1HPGDNPC1
SCHEMBL1895466 0.86 NMT1 (0.49) EGFRALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL1889806 0.83 MET (0.48)
SCHEMBL1132184 0.83 GAA (0.51) EGFRKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL18497845 0.83 LMNA (0.50) EGFRHPGDLMNAPLA2G2AFFAR4
SCHEMBL1895818 0.82 FLT1 (0.46) EGFR
Hydrochloric Acid SCHEMBL1892857 0.82 GAA (0.50) EGFRKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL18525720 0.81 SYK (0.46) EGFRKDM4EMCL1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113924288-B Quinolinyl-containing compound, pharmaceutical composition and application thereof 北京普祺医药科技股份有限公司 2024-04-05 CN disclosed